FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Joachim Kienast

Research Profile

Concepts & Ideas

Procedures

Disorders

Phenomena

Recurrence

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Matthias Stelljes; Renate Arnold; Dietrich W Beelen; Wolfgang E Berdel; Bjorna Berning; Jan Braess; Thomas Büchner; Achim Heinecke; Wolfgang Hiddemann; Ernst Holler; Joachim Kienast; Hans J Kolb; Carsten Müller-Tidow; Maria Cristina Sauerland; Rainer Schwerdtfeger; Hubert Serve; Gerda Silling; Karsten Spiekermann
Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.
Matthias Stelljes; Carsten Müller-Tidow; Claudia Rossig; Richard F Schlenk; Gerda Silling; Wolfgang E Berdel; Andrea Corbacioglu; Hartmut Döhner; Konstanze Döhner; Karoline Ehlert; M C Frühwald; H Juergens; Joachim Kienast; Steffen Koschmieder
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.
Martin Kropff; Joachim Kienast; Guido Bisping; Wolfgang E Berdel; Birgit Gaschler-Markefski; Peter Stopfer; Martin Stefanic; Gerd Munzert
An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joachim Kienast (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Matthias Stelljes; Renate Arnold; Dietrich W Beelen; Wolfgang E Berdel; Bjorna Berning; Jan Braess; Thomas Büchner; Achim Heinecke; Wolfgang Hiddemann; Ernst Holler; Joachim Kienast; Hans J Kolb; Carsten Müller-Tidow; Maria Cristina Sauerland; Rainer Schwerdtfeger; Hubert Serve; Gerda Silling; Karsten Spiekermann
Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial.
Haematologica 2011;96(7):972-9.
2011: Matthias Stelljes; Carsten Müller-Tidow; Claudia Rossig; Richard F Schlenk; Gerda Silling; Wolfgang E Berdel; Andrea Corbacioglu; Hartmut Döhner; Konstanze Döhner; Karoline Ehlert; M C Frühwald; H Juergens; Joachim Kienast; Steffen Koschmieder
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML.
Leukemia 2011;25(7):1209-10.
2009: Martin Kropff; Joachim Kienast; Guido Bisping; Wolfgang E Berdel; Birgit Gaschler-Markefski; Peter Stopfer; Martin Stefanic; Gerd Munzert
An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma.
Anticancer research 2009;29(10):4233-8.
2009: Guido Bisping; Doris Wenning; Martin Kropff; Dirk Gustavus; Carsten Müller-Tidow; Matthias Stelljes; Gerd Munzert; Frank Hilberg; Gerald J Roth; Martin Stefanic; Sarah Volpert; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Bortezomib, dexamethasone, and fibroblast growth factor receptor 3-specific tyrosine kinase inhibitor in t(4;14) myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(2):520-31.
2009: Thomas Büchner; Wolfgang E Berdel; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger; Carsten Müller-Tidow; Jan Braess; Karsten Spiekermann; Joachim Kienast; Peter Staib; Andreas Grüneisen; Wolfgang Kern; Albrecht Reichle; Georg Maschmeyer; Carlo Aul; Eva Lengfelder; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):61-9.
2008: Matthias Stelljes; A van Biezen; S Slavin; E Olavarria; R E Clark; A Nagler; V Koza; Joachim Kienast; Dietger Niederwieser; T de Witte; T Ruutu
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 2008;42(11):739-42.
2008: Johannes Schetelig; Martin Bornhäuser; Christoph Schmid; Bernd Hertenstein; Rainer Schwerdtfeger; Hans Martin; Matthias Stelljes; Ute Hegenbart; Kerstin Schäfer-Eckart; Monika Füssel; Barbel Wiedemann; Christian Thiede; Joachim Kienast; Herrad Baurmann; Arnold Ganser; Hans-Jochem Kolb; Gerhard Ehninger
Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(32):5183-91.
2008: T Meister; H Heinzow; Guido Bisping; Matthias Stelljes; B Schulte; Wolfgang E Berdel; Joachim Kienast; Wolfram Domschke; Hansjörg Ullerich
Intestinal graft-versus-host-disease staging by video capsule endoscopy.
Endoscopy 2008;40 Suppl 2():E144.
2008: Matthias Stelljes; Sven Hermann; Jörn Albring; Gabriele Köhler; Markus Loeffler; Christiane Franzius; Christopher Poremba; Verena Schlösser; Sarah Volkmann; Corinna Opitz; Christoph Bremer; Torsten Kucharzik; Gerda Silling; Otmar Schober; Wolfgang E Berdel; Michael Schäfers; Joachim Kienast
Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography.
Blood 2008;111(5):2909-18.
2008: Charalampia Kyriakou; Carme Canals; Anthony Goldstone; Dolores Caballero; Bernd Metzner; Guido Kobbe; Hans-Jochem Kolb; Joachim Kienast; Peter Reimer; Jurgen Finke; Gunnar Oberg; Ann Hunter; Niklas Theorin; Anna Sureda; Norbert Schmitz
High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):218-24.
2007: Reinhard Lorenz; Joachim Kienast; Ulrich Otto; Michael Kiehl; Dierk Schreiter; Sabine Haertel; Monika Barthels
Successful emergency reversal of phenprocoumon anticoagulation with prothrombin complex concentrate: a prospective clinical study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2007;18(6):565-70.
2007: Martin Kropff; Guido Bisping; Elke Schuck; Peter Liebisch; Nicola Lang; Marcus Hentrich; Tobias Dechow; Nicolaus Kröger; Hans Salwender; Bernd Metzner; Orhan Sezer; Monika Engelhardt; Hans-Heinrich Wolf; Hermann Einsele; Sarah Volpert; Achim Heinecke; Wolfgang E Berdel; Joachim Kienast
Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.
British journal of haematology 2007;138(3):330-7.
2007: Matthias Stelljes; Christiane Specht; Jörn Albring; Sarah Volkmann; Verena Schlösser; Hans-Gerd Pauels; Christopher Poremba; Guido Bisping; Corinna Opitz; christian scheffold; Gerda Silling; Michael Kiehl; Wolfgang E Berdel; Joachim Kienast
Differential requirement for a cellular type-1 immune response in tumor-associated versus alloantigen-targeted GvT effects.
Transplantation 2007;83(3):314-22.
2006: Emma Kulimova; Elisabeth Oelmann; Guido Bisping; Joachim Kienast; Rolf M Mesters; Joachim Schwäble; Frank Hilberg; Gerald J Roth; Gerd Munzert; Martin Stefanic; Björn Steffen; Christian Brandts; Carsten Müller-Tidow; Astrid Kolkmeyer; Thomas Büchner; Hubert Serve; Wolfgang E Berdel
Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors.
Molecular cancer therapeutics 2006;5(12):3105-12.
2006: Martin Kropff; Guido Bisping; Doris Wenning; Wolfgang E Berdel; Joachim Kienast
Proteasome inhibition in multiple myeloma.
European journal of cancer (Oxford, England : 1990) 2006;42(11):1623-39.
2006: Thomas Büchner; Wolfgang E Berdel; Claudia Schoch; Torsten Haferlach; Hubert Serve; Joachim Kienast; Susanne Schnittger; Wolfgang Kern; Joëlle Tchinda; Albrecht Reichle; Eva Lengfelder; Peter Staib; Wolf-Dieter Ludwig; Carlo Aul; Hartmut Eimermacher; Leopold Balleisen; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2480-9.
2006: Johannes N Hoffmann; Christian Wiedermann; Mathias Juers; Helmut Ostermann; Joachim Kienast; Josef Briegel; Richard Strauss; Brian L Warren; Steven M Opal
Benefit/risk profile of high-dose antithrombin in patients with severe sepsis treated with and without concomitant heparin.
Thrombosis and haemostasis 2006;95(5):850-6.
2006: Marcus Hentrich; Karl Fehnle; Helmut Ostermann; Joachim Kienast; Oliver A Cornely; Christoph Salat; Ralf Ubelacker; Dieter Buchheidt; Gerhard Behre; Wolfgang Hiddemann; Xaver Schiel
IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
Critical care medicine 2006;34(5):1319-25.
2006: M Pieper; christian scheffold; S Duwe; Claudia Rossig; Guido Bisping; Matthias Stelljes; T F Tedder; H Jurgens; Wolfgang E Berdel; Joachim Kienast
Immunotherapy of B-cell malignancies with genetically engineered human CD8+ natural killer T cells.
Leukemia 2006;20(4):729-32.
2006: Guido Bisping; Martin Kropff; Doris Wenning; Britta Dreyer; Sergey Bessonov; Frank Hilberg; Gerald J Roth; Gerd Munzert; Martin Stefanic; Matthias Stelljes; christian scheffold; Carsten Müller-Tidow; Peter Liebisch; Nicola Lang; Joëlle Tchinda; Hubert Serve; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Targeting receptor kinases by a novel indolinone derivative in multiple myeloma: abrogation of stroma-derived interleukin-6 secretion and induction of apoptosis in cytogenetically defined subgroups.
Blood 2006;107(5):2079-89.
2006: Christian Wiedermann; Johannes N Hoffmann; Mathias Juers; Helmut Ostermann; Joachim Kienast; Josef Briegel; Richard Strauss; Heinz-Otto Keinecke; Brian L Warren; Steven M Opal
High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety.
Critical care medicine 2006;34(2):285-92.
2006: Michael T Kuhlmann; Paulus Kirchhof; Rainer Klocke; Lekbira Hasib; Jörg Stypmann; Larissa Fabritz; Matthias Stelljes; Wen Tian; Melanie Zwiener; Marcus Mueller; Joachim Kienast; Günter Breithardt; Sigrid Nikol
G-CSF/SCF reduces inducible arrhythmias in the infarcted heart potentially via increased connexin43 expression and arteriogenesis.
The Journal of experimental medicine 2006;203(1):87-97.
2006: Joachim Kienast; Mathias Juers; Christian Wiedermann; Johannes N Hoffmann; Helmut Ostermann; Richard Strauss; Heinz-Otto Keinecke; Brian L Warren; Steven M Opal
Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
Journal of thrombosis and haemostasis : JTH 2006;4(1):90-7.
2006: Martin Bornhäuser; Nicolaus Kröger; Rainer Schwerdtfeger; Karin Schafer-Eckart; Herbert G Sayer; Christoph Scheid; Matthias Stelljes; Joachim Kienast; Peter Mundhenk; Stefan Fruehauf; Michael Kiehl; Hannes Wandt; Catrin Theuser; Gerhard Ehninger; Axel R Zander
Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
European journal of haematology 2006;76(1):9-17.
2006: Erhard Severin; Burkhard Greve; Elke Pascher; Niels Wedemeyer; Ursula Hacker-Klom; Gerda Silling; Joachim Kienast; Normann Willich; Wolfgang Göhde
Evidence for predictive validity of blood assays to evaluate individual radiosensitivity.
International journal of radiation oncology, biology, physics 2006;64(1):242-50.
2005: Thomas Büchner; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Torsten Haferlach; Susanne Schnittger; Wolfgang Kern; Carlo Aul; Eva Lengfelder; Andrea Schumacher; Albrecht Reichle; Peter Staib; Leopold Balleisen; Hartmut Eimermacher; Andreas Grüneisen; Herbert Rasche; Maria Cristina Sauerland; Achim Heinecke; Rolf M Mesters; Hubert Serve; Joachim Kienast; Wolfgang Hiddemann
Treatment of older patients with AML.
Critical reviews in oncology/hematology 2005;56(2):247-59.
2005: Matthias Stelljes; Martin Bornhauser; Matthias Kroger; Jörg Beyer; Maria Cristina Sauerland; Achim Heinecke; Bjorna Berning; christian scheffold; Gerda Silling; Thomas Buchner; Andreas Neubauer; Axel A Fauser; Gerhard Ehninger; Wolfgang E Berdel; Joachim Kienast
Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.
Blood 2005;106(9):3314-21.
2005: Christian G Erker; Martin B Steins; Rudolf-Josef Fischer; Joachim Kienast; Wolfgang E Berdel; Walter Sibrowski; Uwe Cassens
The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation.
Transfusion 2005;45(8):1382-90.
2005: Martin Kropff; Guido Bisping; Doris Wenning; Sarah Volpert; Joëlle Tchinda; Wolfgang E Berdel; Joachim Kienast
Bortezomib in combination with dexamethasone for relapsed multiple myeloma.
Leukemia research 2005;29(5):587-90.
2004: Joëlle Tchinda; Sarah Volpert; Martin Kropff; Wolfgang E Berdel; Joachim Kienast; Friedhelm Meinhardt; Jürgen Horst
Frequent gains of the short arm of chromosome 9 in multiple myeloma with normal G-banded karyotype detected by comparative genomic hybridization.
American journal of clinical pathology 2004;122(6):875-82.
2004: christian scheffold; M Kroeger; M Zuehlsdorf; Joëlle Tchinda; Gerda Silling; Guido Bisping; Matthias Stelljes; Thomas Buechner; Wolfgang E Berdel; Joachim Kienast
Prediction of relapse of acute myeloid leukemia in allogeneic transplant recipients by marrow CD34+ donor cell chimerism analysis.
Leukemia 2004;18(12):2048-50.
2004: Uwe Cassens; Ingo Mathias Barth; Claudia Baumann; Rudolf-Josef Fischer; Joachim Kienast; Josef Vormoor; Walter Sibrowski
Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukaphereses with standardized processing volumes.
Transfusion 2004;44(11):1593-602.
2004: Elisabeth Oelmann; Susan Haghgu; Emma Kulimova; Rolf M Mesters; Joachim Kienast; Hermann Herbst; Christiane Schmitmann; Astrid Kolkmeyer; Hubert Serve; Wolfgang E Berdel
Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-fluorouracil in vitro.
International journal of oncology 2004;25(4):1001-12.
2004: Matthias Stelljes; Robert Strothotte; Hans-Gerd Pauels; Christopher Poremba; Michaela Milse; Christiane Specht; Jörn Albring; Guido Bisping; christian scheffold; Thomas Kammertoens; Elisabeth Oelmann; Gerda Silling; Wolfgang E Berdel; Joachim Kienast
Graft-versus-host disease after allogeneic hematopoietic stem cell transplantation induces a CD8+ T cell-mediated graft-versus-tumor effect that is independent of the recognition of alloantigenic tumor targets.
Blood 2004;104(4):1210-6.
2004: Michael Kiehl; Ludwig Kraut; Rainer Schwerdtfeger; Bernd Hertenstein; Mats Remberger; Nicolaus Kroeger; Mathias Stelljes; Martin Bornhaeuser; Hans Martin; Christoph Scheid; Arnold Ganser; Axel R Zander; Joachim Kienast; Gerhard Ehninger; Dieter Hoelzer; Volker Diehl; Axel A Fauser; Olle Ringden
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2816-25.
2004: Martin B Steins; Teresa Padró; Carsten Schwaenen; Sandra Ruiz; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2004;15(5):383-91.
2004: Joachim Kienast; Wolfgang E Berdel
c-maf in multiple myeloma: an oncogene enhancing tumor-stroma interactions.
Cancer cell 2004;5(2):109-10.
2004: Joachim Kienast; Matthias Stelljes; Bjorna Berning; Matthias Kröger; Maria Cristina Sauerland; Achim Heinecke; Claudia Schoch; Bernhard Wörmann; Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel
Transplantation strategies in AML: AMLCG data.
Annals of hematology 2004;83 Suppl 1():S136-7.
2004: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Christa Fonatsch; Helmut Löffler; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; Leopold Balleisen; Andreas Grüneisen; Carlo Aul; Eva Lengfelder; Rüdiger Hehlmann; Wolfgang Kern; Hubert Serve; Rolf M Mesters; Hartmut Eimermacher; Norbert Frickhofen; Joachim Kienast; A Giagounidis; Maria Cristina Sauerland; Achim Heinecke
Subgroup specific therapy effects in AML: AMLCG data.
Annals of hematology 2004;83 Suppl 1():S100-1.
2003: Ralf Bieker; Teresa Padró; Julia Kramer; Martin B Steins; Torsten Kessler; Stephan Retzlaff; Federico Herrera; Joachim Kienast; Wolfgang E Berdel; Rolf M Mesters
Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.
Cancer research 2003;63(21):7241-6.
2003: Hermann Einsele; Hartmut Bertz; Jörg Beyer; Michael Kiehl; Volker Runde; Hans-Jochen Kolb; Ernst Holler; Robert Beck; Rainer Schwerdfeger; Ulrike Schumacher; Holger Hebart; Hans Martin; Joachim Kienast; Andrew J Ullmann; Georg Maschmeyer; William Krüger; Dietger Niederwieser; Hartmut Link; Christian A Schmidt; Helmut Oettle; Thomas Klingebiel
Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).
Annals of hematology 2003;82 Suppl 2():S175-85.
2003: Martin B Steins; Ralf Bieker; Teresa Padró; Torsten Kessler; Joachim Kienast; Wolfgang E Berdel; Rolf M Mesters
Thalidomide for the treatment of acute myeloid leukemia.
Leukemia & lymphoma 2003;44(9):1489-93.
2003: Martin Kropff; Nicola Lang; Guido Bisping; Nicole Dominé; Georg Innig; Marcus Hentrich; Manfred Mitterer; Thomas Südhoff; Roland Fenk; Christian Straka; Achim Heinecke; Olaf M Koch; Helmut Ostermann; Wolfgang E Berdel; Joachim Kienast
Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma.
British journal of haematology 2003;122(4):607-16.
2003: Johannes Schetelig; Christian Thiede; Martin Bornhauser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Herbert G Sayer; N Kroger; M Hensel; christian scheffold; Thomas K Held; K Hoffken; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Evidence of a graft-versus-leukemia effect in chronic lymphocytic leukemia after reduced-intensity conditioning and allogeneic stem-cell transplantation: the Cooperative German Transplant Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(14):2747-53.
2003: Herbert G Sayer; Matthias Kröger; Jörg Beyer; Michael Kiehl; S A Klein; K Schaefer-Eckart; Rainer Schwerdtfeger; Wolfgang Siegert; Volker Runde; Catrin Theuser; H Martin; Johannes Schetelig; D W Beelen; Axel A Fauser; Joachim Kienast; Klaus Höffken; Gerhard Ehninger; Martin Bornhäuser
Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor.
Bone marrow transplantation 2003;31(12):1089-95.
2003: Annette Nolte; christian scheffold; Janina Slotty; Colette Huenefeld; Joachim L Schultze; Stefan Grabbe; Wolfgang E Berdel; Joachim Kienast
Generation of melanoma-specific cytotoxic T lymphocytes for allogeneic immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(3):257-69.
2003: Guido Bisping; Regine Leo; Doris Wenning; Berno Dankbar; Teresa Padró; Martin Kropff; christian scheffold; Matthias Kröger; Rolf M Mesters; Wolfgang E Berdel; Joachim Kienast
Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma.
Blood 2003;101(7):2775-83.
2003: Reinhard Lorenz; Joachim Kienast; Ulrich Otto; Klaus Egger; Michael Kiehl; Dierk Schreiter; Harald Kwasny; Sabine Haertel; Monika Barthels
Efficacy and safety of a prothrombin complex concentrate with two virus-inactivation steps in patients with severe liver damage.
European journal of gastroenterology & hepatology 2003;15(1):15-20.
2002: Michael Kiehl; K Schäfer-Eckart; Matthias Kröger; Martin Bornhäuser; Nadezda Basara; Igor Wolfgang Blau; Joachim Kienast; Axel A Fauser; Gerhard Ehninger; V W Armstrong; Maria Shipkova
Mycophenolate mofetil for the prophylaxis of acute graft-versus-host disease in stem cell transplant recipients.
Transplantation proceedings 2002;34(7):2922-4.
2002: Teresa Padró; Ralf Bieker; Sandra Ruiz; Martin B Steins; Stephan Retzlaff; H Bürger; Thomas Büchner; Torsten Kessler; F Herrera; Joachim Kienast; Carsten Müller-Tidow; Hubert Serve; Wolfgang E Berdel; Rolf M Mesters
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
Leukemia 2002;16(7):1302-10.
2002: Teresa Padró; Rolf M Mesters; Berno Dankbar; Heike Hintelmann; Ralf Bieker; Michael Kiehl; Wolfgang E Berdel; Joachim Kienast
The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells.
Journal of cell science 2002;115(Pt 9):1961-71.
2002: Martin B Steins; Teresa Padró; Ralf Bieker; Sandra Ruiz; Martin Kropff; Joachim Kienast; Torsten Kessler; Thomas Buechner; Wolfgang E Berdel; Rolf M Mesters
Efficacy and safety of thalidomide in patients with acute myeloid leukemia.
Blood 2002;99(3):834-9.
2002: Johannes Schetelig; Christian Thiede; Martin Bornhäuser; Rainer Schwerdtfeger; Michael Kiehl; Jörg Beyer; Nicolaus Kröger; M Hensel; christian scheffold; A D Ho; Joachim Kienast; Andreas Neubauer; Axel R Zander; Axel A Fauser; Gerhard Ehninger; Wolfgang Siegert
Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia.
Annals of hematology 2002;81 Suppl 2():S47-8.
2002: Elisabeth Oelmann; Michael Thomas; Hubert Serve; Joachim Kienast; Michael Zühlsdorf; M Mohr; Folker Klinke; G Dölken; Hans-Nicol Macha; E W Schmidt; Wolfgang E Berdel
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
Oncology 2002;63(3):248-53.
2001: Hermann Einsele; Hartmut Bertz; Jörg Beyer; Michael Kiehl; Volker Runde; H J Kolb; E Holler; R Beck; R Schwerdfeger; U Schumacher; Holger Hebart; H Martin; Joachim Kienast; A J Ullmann; Georg Maschmeyer; William Krüger; H Link; Christian A Schmidt; Helmut Oettle; T Klingebiel
[Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation].
Deutsche medizinische Wochenschrift (1946) 2001;126(45):1278-84.
2001: Rolf M Mesters; Teresa Padró; Martin B Steins; Ralf Bieker; Stephan Retzlaff; Torsten Kessler; Joachim Kienast; Wolfgang E Berdel
[Angiogenesis in patients with hematologic malignancies].
Onkologie 2001;24 Suppl 5():75-80.
2001: Uwe Cassens; P H Momkvist; M Zuehlsdorf; M Mohr; Joachim Kienast; Wolfgang E Berdel; Walter Sibrowski
Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).
Bone marrow transplantation 2001;28(1):13-20.
2001: M Mohr; F Dalmis; Eva Hilgenfeld; Elisabeth Oelmann; Michael Zühlsdorf; K Kratz-Albers; Annette Nolte; Christiane Schmitmann; D Onaldi-Mohr; Uwe Cassens; Hubert Serve; Walter Sibrowski; Joachim Kienast; Wolfgang E Berdel
Simultaneous immunomagnetic CD34+ cell selection and B-cell depletion in peripheral blood progenitor cell samples of patients suffering from B-cell non-Hodgkin's lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(1):51-7.
2000: Masao Mizuki; R Fenski; Hartmut Halfter; Itaru Matsumura; R Schmidt; C Müller; W Grüning; K Kratz-Albers; S Serve; Claudia Steur; Thomas Büchner; Joachim Kienast; Yuzuru Kanakura; Wolfgang E Berdel; Hubert Serve
Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways.
Blood 2000;96(12):3907-14.
2000: Teresa Padró; Sandra Ruiz; Ralf Bieker; H Bürger; Martin B Steins; Joachim Kienast; Thomas Büchner; Wolfgang E Berdel; Rolf M Mesters
Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.
Blood 2000;95(8):2637-44.
2000: Berno Dankbar; Teresa Padró; Regine Leo; B Feldmann; Martin Kropff; Rolf M Mesters; Hubert Serve; Wolfgang E Berdel; Joachim Kienast
Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.
Blood 2000;95(8):2630-6.
2000: R Fenski; K Flesch; S Serve; Masao Mizuki; Elisabeth Oelmann; K Kratz-Albers; Joachim Kienast; Regine Leo; Stefan Schwartz; Wolfgang E Berdel; Hubert Serve
Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cells.
British journal of haematology 2000;108(2):322-30.
1999: Martin B Steins; Teresa Padró; CX Li; Rolf M Mesters; Helmut Ostermann; Dieter Hammel; Hans H Scheld; Wolfgang E Berdel; Joachim Kienast
Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries.
Atherosclerosis 1999;145(1):173-80.
1999: M Mohr; Eva Hilgenfeld; Thomas Fietz; B Hoppe; M Koenigsmann; M Hoffmann; Wolfgang Knauf; Uwe Cassens; Walter Sibrowski; Joachim Kienast; Eckhard Thiel; Wolfgang E Berdel
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):1035-40.
1999: Helmut Ostermann; Hans Günter Derigs; Gudula Heussel; Winfried V Kern; Michael Kiehl; Joachim Kienast; Rolf M Mesters; Xaver Schiel; R R Schumann; M Weiss
[Sepsis in neutropenia. Standard recommendations of the Work Group of Infections in Hematology and Oncology of the German Association for Hematology and Oncology].
Deutsche medizinische Wochenschrift (1946) 1999;124 Suppl 1():S14-7.
1999: B Hoppe; M Mohr; A Roots-Weiss; Joachim Kienast; Wolfgang E Berdel
Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells.
Bone marrow transplantation 1999;23(8):809-17.
1998: Michael Kiehl; Helmut Ostermann; M Thomas; C Müller; Uwe Cassens; Joachim Kienast
Inflammatory mediators in bronchoalveolar lavage fluid and plasma in leukocytopenic patients with septic shock-induced acute respiratory distress syndrome.
Critical care medicine 1998;26(7):1194-9.
1998: Joachim Kienast; Teresa Padró; Martin B Steins; CX Li; K W Schmid; Dieter Hammel; Hans H Scheld; Jürgen van de Loo
Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries.
Thrombosis and haemostasis 1998;79(3):579-86.
1997: Michael Kiehl; Helmut Ostermann; M Thomas; T Birkfellner; Joachim Kienast
Inflammatory mediators in BAL fluid as markers of evolving pneumonia in leukocytopenic patients.
Chest 1997;112(5):1214-20.
1997: Teresa Padró; Martin B Steins; CX Li; Rolf M Mesters; Dieter Hammel; Hans H Scheld; Joachim Kienast
Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants.
Cardiovascular research 1997;36(1):28-36.
1997: Helmut Ostermann; K Kratz-Albers; Rolf M Mesters; Michael Kiehl; Joachim Kienast
Reciprocal changes in circulating interleukin-6 and its soluble receptor during evolving sepsis in leukocytopenic patients.
The Journal of infectious diseases 1997;176(3):825-8.
1997: Michael Kiehl; Helmut Ostermann; Jörg Meyer; Joachim Kienast
Nitric oxide synthase inhibition by L-NAME in leukocytopenic patients with severe septic shock.
Intensive care medicine 1997;23(5):561-6.
1997: Uwe Cassens; P Ostkamp-Ostermann; Henk Garritsen; Reinhard Kelsch; Helmut Ostermann; Joachim Kienast; Michael Kiehl; Thomas Buechner; Jürgen van de Loo; H Juergens; Walter Sibrowski
Efficacy and kinetics of bone marrow processing and enrichment of haematopoietic progenitor cells (HPC) by a large-volume apheresis procedure.
Bone marrow transplantation 1997;19(8):835-40.
1996: Rolf M Mesters; P M Mannucci; R Coppola; T Keller; Helmut Ostermann; Joachim Kienast
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.
Blood 1996;88(3):881-6.
1996: Rolf M Mesters; N Flörke; Helmut Ostermann; Joachim Kienast
Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.
Thrombosis and haemostasis 1996;75(6):902-7.
1996: Michael Kiehl; C Schiele; W Stenzinger; Joachim Kienast
Volume-controlled versus biphasic positive airway pressure ventilation in leukopenic patients with severe respiratory failure.
Critical care medicine 1996;24(5):780-4.
1996: Simon G Thompson; C Fechtrup; E Squire; U Heyse; G Breithardt; Jürgen van de Loo; Joachim Kienast
Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.
Arteriosclerosis, thrombosis, and vascular biology 1996;16(3):357-62.
1995: Rolf M Mesters; T Mikoteit; M Schiller; W Krings; Helmut Ostermann; Joachim Kienast
Markers of coagulation activation for evaluation of the antithrombotic efficacy of heparin: a prospective study in acute deep venous thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(7):665-71.
1995: Teresa Padró; J J Emeis; Martin B Steins; K W Schmid; Joachim Kienast
Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.
Arteriosclerosis, thrombosis, and vascular biology 1995;15(7):893-902.
1995: Simon G Thompson; Joachim Kienast; S D Pyke; Frits Haverkate; Jürgen van de Loo
Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
The New England journal of medicine 1995;332(10):635-41.
1994: P Close; J Bichler; R Kerry; S Ekman; H R Bueller; Joachim Kienast; GA Marbet; Wolfgang Schramm; M Verstraete
Weak allergenicity of recombinant hirudin CGP 39393 (REVASC) in immunocompetent volunteers. The European Hirudin in Thrombosis Group (HIT Group).
Coronary artery disease 1994;5(11):943-9.
1994: Helmut Ostermann; M Rothenburger; Rolf M Mesters; Jürgen van de Loo; Joachim Kienast
Cytokine response to infection in patients with acute myelogenous leukaemia following intensive chemotherapy.
British journal of haematology 1994;88(2):332-7.
1993: S D Pyke; Simon G Thompson; R Buchwalsky; Joachim Kienast
Variability over time of haemostatic and other cardiovascular risk factors in patients suffering from angina pectoris. ECAT Angina Pectoris Study Group.
Thrombosis and haemostasis 1993;70(5):743-6.
1993: Joachim Kienast; Simon G Thompson; C Raskino; H Pelzer; C Fechtrup; Helmut Ostermann; Jürgen van de Loo
Prothrombin activation fragment 1 + 2 and thrombin antithrombin III complexes in patients with angina pectoris: relation to the presence and severity of coronary atherosclerosis.
Thrombosis and haemostasis 1993;70(4):550-3.
1993: M Verstraete; M Nurmohamed; Joachim Kienast; Matthias Siebeck; G Silling-Engelhardt; H Büller; Bernard Hoet; J Bichler; P Close
Biologic effects of recombinant hirudin (CGP 39393) in human volunteers. European Hirudin in Thrombosis Group.
Journal of the American College of Cardiology 1993;22(4):1080-8.
1993: GA Marbet; M Verstraete; Joachim Kienast; P Graf; Bernard Hoet; Dimitrios A Tsakiris; G Silling-Engelhardt; P Close
Clinical pharmacology of intravenously administered recombinant desulfatohirudin (CGP 39393) in healthy volunteers.
Journal of cardiovascular pharmacology 1993;22(3):364-72.
1993: I Bolibar; Joachim Kienast; Simon G Thompson; R Matthias; H Niessner; C Fechtrup
Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Pectoris Study Group.
American heart journal 1993;125(6):1601-5.
1993: G Pfliegler; Jef Arnout; Joachim Kienast; Christine Wittevrongel; Bernard Hoet; Hans Deckmyn; Jos Vermylen
Sodium fluoride induced activation of phospholipase C in intact human platelets does not depend on ADP, PAF or arachidonate products.
Thrombosis research 1993;69(6):541-5.
1993: Joachim Kienast; Helmut Ostermann
[Blood coagulation and fibrinolysis].
Zeitschrift für Kardiologie 1993;82 Suppl 2():65-9.
1992: Helmut Ostermann; Joachim Kienast
[The value of laboratory diagnosis in thrombolytic therapy].
Der Internist 1992;33(4):252-7.
1992: Joachim Kienast; G Silling-Engelhardt
[Thrombolytic therapy of pulmonary embolism].
Der Internist 1992;33(4):216-24.
1991: Joachim Kienast; Jürgen van de Loo
[Lysis therapy in deep leg vein thrombosis and pulmonary embolism after hip surgery?].
Deutsche medizinische Wochenschrift (1946) 1991;116(17):676-7.
1990: Joachim Kienast; Jef Arnout; Hans Deckmyn; B Van der Schueren; Jos Vermylen
Non-receptor-mediated refractoriness in prostacyclin production by human endothelial cells in a continuous flow system is delayed by a low-molecular-weight plasma fraction devoid of reducing cofactors for peroxidase-catalysed reactions.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1990;1(6):609-18.
1990: Chris Van Geet; Hans Deckmyn; Joachim Kienast; Christine Wittevrongel; Jos Vermylen
Guanine nucleotide-dependent inhibition of phospholipase C in human endothelial cells.
The Journal of biological chemistry 1990;265(14):7920-6.
1990: Joachim Kienast; Gerd Schmitz
Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders.
Blood 1990;75(1):116-21.
1989: Joachim Kienast; Helmut Ostermann; W Stenzinger; E M Kötter; Jürgen van de Loo
[Anti-phospholipid antibody with recurrent venous thromboembolism and severe autoimmune thrombocytopenia].
Klinische Wochenschrift 1989;67(13):691-5.
1989: B Lenfers; Joachim Kienast; J van de Loo
Different pathways initiating arachidonic acid (AA) release/thromboxane (TxA2) formation in human platelets--studies with fluoride and phorbol ester.
Progress in clinical and biological research 1989;301():309-14.
1989: Chris Van Geet; Hans Deckmyn; Joachim Kienast; Christine Wittevrongel; Jos Vermylen
Dual effect of fluoride on endothelial prostacyclin production: a phospholipase C mediated phenomenon.
Progress in clinical and biological research 1989;301():377-81.
1987: Joachim Kienast; Jef Arnout; G Pfliegler; Hans Deckmyn; Bernard Hoet; Jos Vermylen
Sodium fluoride mimics effects of both agonists and antagonists on intact human platelets by simultaneous modulation of phospholipase C and adenylate cyclase activity.
Blood 1987;69(3):859-66.
1986: Joachim Kienast; Jef Arnout; Hans Deckmyn; G Pfliegler; Bernard Hoet; Jos Vermylen
On the role of guanine nucleotide binding regulatory proteins (G-proteins) in signal transduction in human platelets: studies with sodium fluoride (NaF).
Agents and actions. Supplements 1986;20():175-80.